Bio
Dr. Shawn Barton is a board-certified, fellowship-trained neurologist with the Stanford Health Care Movement Disorders Center. He specializes in movement disorders, such as Parkinson’s disease, essential tremor, and dystonia. With a deep understanding of neuroscience, he expertly diagnoses and treats many neurodegenerative and genetic conditions. He provides compassionate care focused on relieving symptoms and improving everyday life.
During his doctoral studies, Dr. Barton investigated drug delivery and the development of novel biomarkers in Alzheimer’s disease using preclinical mouse models. As a physician-scientist, his research interests include identifying biomarkers for Parkinson's disease and other neurodegenerative diseases. He also focuses on developing clinical trials to advance potential disease-modifying therapies.
Dr. Barton has published his findings in several peer-reviewed journals, including Science, Journal of Alzheimer’s Disease, and Journal of Biomolecular NMR. He also has presented at national conferences, including annual meetings of the American Academy of Neurology and the Society of General Internal Medicine. He has shared his research on a range of topics, including identifying methods of increasing blood-brain barrier penetrance for therapeutic delivery and using inhaled fluorescent markers to detect amyloid-beta plaques (a protein known to build up in the brain with Alzheimer’s disease) in the retina.
Dr. Barton is a member of the American Academy of Neurology, American Neurological Association, and International Parkinson and Movement Disorder Society.
